Skip to content

Week 2 clinical drug teaching 162

  • by

Ziprasidone and Seroquel

Hi everyone my name is nicole kistelenick and today i will be teaching the drugs suprasidone and seroquel so cebrazodone class is that it is an antipsychotic and a mood stabilizer it is used for patients that have schizophrenia and bipolar disorder the action of zaprazodone is that it inhibits synaptic reuptake of serotonin and norepinephrine some signs side

Effects of zaprazodone are that you can have neuroleptic syndrome develop you can have seizures prolonged qt intervals orthostatic hypotension a granulocytosis dizziness restlessness extrapyramidal reactions synscope hyperglycemia hyperlipidemia and from that weight gain and you can also develop a rash considerations related to certain diagnostic tests would

Be that the nurse should monitor the serum potassium and the serum magnesium levels prior to and periodically during the therapy they should monitor the cbc frequently in the first initial month of the therapy in patients with history of and pre-existing conditions of low white blood cell counts nutrition aspects of taking this drug is that it should be taken

With food and that the meal should be equal to or greater than 500 calories um the reason for this that is that it’s required for optimal repo reproducible bio activity bio availability of the administered dose sorry about that contraindications um of somebody to take this drug is that if they are experiencing hypersensitivity arrhythmias if they had a recent mi

If a woman is breastfeeding the nurse should advise the mother to bottle feed the child um if the patient is taking antiarrhythmic drugs throughout this medication the nurse should monitor the patient’s mood they should assess the patient’s weight and bmi prior to the therapy and during the therapy to assess for weight gain and they should monitor the patient

For orthostatic do their orthostatic blood pressure throughout the therapy as well to monitor make sure that they aren’t having orthostatic hypertension next would be seroquel so seroquel as well as the protozoan is an antipsychotic medication and a mood stabilizer which means that is also used for patients with schizophrenia and bipolar disorder the action

Of seroquel is it acts by serving as an antagonist of dopamine and serotonin some side effects of seroquel are the neuroleptic malignant syndrome pancreatitis tardive dyskinsia anorexia stevens-johnson syndrome dry mouth cognitive impairments dizziness extra pyramidal symptoms ear pain palpitations peripheral edema hyperglycemia hyperlipidemia and weight gain

I don’t know about some of you but i’ve seen through a lot of the anti-psychotic medications that some of their side effects are the same like the extra the extrapyramidal symptoms the tardive dyskinesia the neuroleptic malignant syndrome and weight gain so i find that kind of interesting and it kind of stood out to me so considerations related to diagnostic

Tests um related to cerakril would be that cerequil can cause anemia and increase the total cholesterol levels in patients and the nurse should monitor the serum prolactin levels the nutrition aspect of seroquel is that it can be taken with or without food for the extended release it should be taken without food or with a light meal so less than or equal to 300

Calories some contraindications would be that if the patient has a history of arrhythmias if lactation as well and hypersensitivity so throughout taking this medication the nurse should monitor the patient’s mood as well they should assess for suicidal tendencies they should assess for weight um weight gain and bmi so like i said before um prior to them even

Starting the medication they should take their weight and bmi and compare that throughout the therapy to make sure that they aren’t gaining any weight they should monitor their orthostatic blood pressure they should assess for development of a rash and they should monitor for the development of neuroleptic malignant syndrome okay guys that’s all i have for you have a good day

Transcribed from video
Week 2 clinical drug teaching 162 By Nicole Kistulinec